abstract |
The invention is concerned with novel anthranilic acid derivatives of formula (I) n n n n n n n n n n wherein R 1 to R 14 , m and n are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds are HM74A agonists and can be used as medicaments. |